SynopsisCenicriviroc is an experimental drug candidate for the treatment of HIV infection.Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell. The global .....
SynopsisMizolastine is a second generation antihistamine agent with high affinity and specificity for histamine H1 receptors. The global Mizolastine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % .....
SynopsisBepotastine is a non-sedating, selective antagonist of histamine 1 (H1) receptor with pIC50 of 5.7. The global Bepotastine Besilate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during th.....
SynopsisTocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis. The global Toci.....
SynopsisIndoximod, a methylated tryptophan, acts as an IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, and reverses IDO-mediated immune suppression. The global Indoximod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2.....
SynopsisEpacadostat is a potent and selective indoleamine 2,3-dioxygenase (IDO1) inhibitor. The global Epacadostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-20.....
SynopsisErianin, a natural product derived from Dendrobium chrysotoxum, has been used as an analgesic in traditional Chinese medicine and is a potential anti-tumor agent. Erianin can inhibit IDO-induced tumor angiogenesis. The global Erianin market was valued at.....
SynopsisCoptisin chloride is an MAO-A inhibitor. Coptisin chloride is a bacterial collagenase inhibitor. The global Coptisine Chloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the for.....
SynopsisApocynin is a compound isolated from the traditional medicinal plant P. kurroa and structurally related to vanillin that acts as an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. The global Apocynin market was valued a.....
SynopsisZanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
